00:42 , Aug 12, 2017 |  BioCentury  |  Product Development

HBV test kitchen

Early results for HBV monotherapies are pointing the way toward combinations that could deliver a functional cure. What remains unknown is how many components, and which ones, will prove necessary to eliminate remnants of the...
01:41 , Dec 30, 2016 |  BC Week In Review  |  Company News

Spring Bank, Arbutus deal

The companies partnered to conduct preclinical studies combining Spring Bank's SB 9200 and Arbutus' AB-423 to treat HBV infection. SB 9200, a small molecule targeting DEAD box polypeptide 58 (DDX58; RIG-1) and caspase recruitment domain...